LivaNova: Heart Failure trials

The registry lists 14 Heart Failure studies with LivaNova as lead sponsor. 0 are open to participants now and 1 have results posted.

Phase 1 1Phase 2 2Phase 3 3Phase 4 3No phase 6(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Clinical Evaluation of LEft VEntricular Auto Threshold Algorithm (LEVEA)CompletedNCT03014180Not applicableResults posted
• ANTHEM-HFrEF Pivotal StudyTerminatedNCT03425422Not applicable
• Autonomic Regulation Therapy in Heart Failure With Preserved Ejection FractionCompletedNCT03163030Not applicable
• Left Ventricular Pacing Vectors Effectiveness to Narrow Phrenic Nerve StimulationCompletedNCT03127202Not applicable
• Sleep Apnea, Arrhythmias and Cardiac Reverse Remodeling in Heart Failure PatientsWithdrawnNCT02870647Phase 4
• VITARIA Registry StudySuspendedNCT02545582
• Clinical Evaluation of the Physiological Diagnosis Function in the PARADYM CRT DeviceCompletedNCT02167789Phase 3
• VAgal Nerve Stimulation: safeGUARDing Heart Failure PatientsCompletedNCT02113033Phase 2
• Autonomic Neural Regulation Therapy to Enhance Myocardial Function in Heart Failure (ANTHEM-HF) StudyCompletedNCT01823887Phase 1/2
• Clinical Evaluation Of The PARADYM RF DeviceCompletedNCT01193634Phase 3
• Clinical Status Monitoring in Implantable Cardiac Defibrillator (ICD) Patients by Physiological Diagnosis (PhD) FunctionTerminatedNCT01170624Phase 4
• Clinical Evaluation Of The SonR Atrial Lead In Paradym RF DeviceCompletedNCT01169272Phase 3
• Echocardiography and Peak Endocardial Acceleration (PEA) Measurements in Cardiac Resynchronization Therapy (CRT)CompletedNCT01066078
• Clinical Evaluation on Advanced ResynchronizationCompletedNCT00658203Phase 4